烟囱技术与开窗支架联合治疗复杂主动脉瘤
本研究在高容量中心回顾性分析45例复杂主动脉瘤患者,采用烟囱联合开窗支架腔内修复(chFEVAR),技术成功率93.3%,30天死亡率13.3%,靶血管通畅率96.0%,结论认为该技术可行,适用于急诊及高度选择病例。
要点
- chFEVAR技术成功率93.3%,动脉瘤成功隔绝率97.8%。
- 30天死亡率13.3%,靶血管通畅率96.0%。
- 12个月免于动脉瘤相关再干预率仅59.2%。
核心结论
- 联合chFEVAR技术可行性良好,可作为急诊及FEVAR不可行的高度选择病例的有效方法。
- 30天死亡率、靶血管通畅率和Ia型内漏率可接受。
研究设计与样本
- 单中心回顾性研究,2011年7月至2016年7月纳入45例复杂主动脉瘤患者(平均年龄73.0±8.8岁,39例男性)。
- 患者均不适合开放手术且解剖上不适合标准或定制开窗支架,其中8例(18%)为急诊手术。
主要发现
- 动脉瘤成功隔绝率97.8%(44/45),成功重建率98.2%(107/109血管,排除扇形支架),技术成功率93.3%(42/45)。
- 30天内6例(13.3%)死亡,其中5例院内死亡。
- 12个月总生存率85.9%,免于动脉瘤相关死亡88.5%,免于动脉瘤相关再干预59.2%。
- 靶血管通畅率96.0%;最新随访时存在1例Ia型内漏和3例II型内漏;18例(54%)患者出现瘤囊缩小。
关键数值与推荐
- 共处理130根靶血管(每例2.9根),采用21个扇形支架、42个开放/18个覆膜烟囱支架、27个定制/22个自制开窗。
临床怎么用
- 对于不适合开放手术且解剖条件不适合标准或定制开窗支架的复杂主动脉瘤患者,可考虑chFEVAR。
- 在急诊情况下,chFEVAR可作为FEVAR不可行时的替代方案。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To present early results of fenestrated endovascular aneurysm repair (FEVAR) combined with chimney grafts in a high-volume center. METHODS: From July 2011 to July 2016, 45 patients (mean age 73.0±8.8 years; 39 men) with complex aneurysms who were poor candidates for open repair and anatomically ineligible for standard or custom-made FEVAR were treated with chimney FEVAR (chFEVAR). Eight (18%) cases were treated in emergency. In all, 130 target vessels (2.9/patient) were addressed using 21 scallops, 42 open/18 covered chimneys, and 27 custom-made/22 homemade fenestrations. RESULTS: Successful aneurysm exclusion, successful reconstruction, and technical success rates were 97.8% (44/45), 98.2% (107/109 vessels excluding the scallops), and 93.3% (42/45). Six (13.3%) patients died within 30 days (5 in hospital). Estimated overall survival, freedom from aneurysm-related death, and freedom from aneurysm-related reintervention were 85.9%, 88.5%, and 59.2%, respectively, at 12 months. The target vessel patency rate was 96.0%. At latest follow-up, 1 type Ia and 3 type II endoleaks were present. Sac shrinkage occurred in 18 (54%) patients. CONCLUSION: Combined chFEVAR showed good technical feasibility and could be an effective approach in emergent settings and highly selective cases when FEVAR is not feasible. Thirty-day mortality, target vessel patency, and type Ia endoleak rates were acceptable.
引用
- Caradu C, Morin J, Midy D, et al. Combination of Chimneys and Fenestrated Endografts in the Treatment of Complex Aortic Aneurysms. J Endovasc Ther. 2017. PMID: 28602114. doi:10.1177/1526602817713472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。